James Condulis
Stock Analyst at Stifel
(2.69)
# 2,167
Out of 5,090 analysts
8
Total ratings
66.67%
Success rate
17.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7.5 → $10 | $3.84 | +160.42% | 1 | Dec 5, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $24 | $13.49 | +77.91% | 1 | Sep 29, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $65.57 | +46.41% | 2 | Sep 2, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $34.95 | +25.89% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $51.07 | +111.47% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $23.93 | +25.37% | 1 | Jan 22, 2025 |
X4 Pharmaceuticals
Dec 5, 2025
Maintains: Buy
Price Target: $7.5 → $10
Current: $3.84
Upside: +160.42%
Aardvark Therapeutics
Sep 29, 2025
Initiates: Buy
Price Target: $24
Current: $13.49
Upside: +77.91%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $65.57
Upside: +46.41%
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $34.95
Upside: +25.89%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $51.07
Upside: +111.47%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $23.93
Upside: +25.37%